+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
MALE
ID07365995

Randomized Open-Label Study Comparing BNT324 and Docetaxel with PrednisonePrednisolone for Metastatic Castration-Resistant Prostate Cancer

Led by BioNTech SE · Updated on 2026-10-16

736

Participants Needed

52

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating BNT324 compared to the standard chemotherapy docetaxel combined with prednisone or prednisolone in men with metastatic castration-resistant prostate cancer mCRPC who have been previously treated with androgen receptor pathway inhibitors but have not received taxane-based chemotherapy for mCRPC. This phase III trial aims to determine if BNT324 can help participants live longer without their cancer worsening and improve overall survival. Participants are randomly assigned to one of two groups receiving BNT324 through intravenous infusion or receiving docetaxel intravenously along with oral prednisone or prednisolone. Treatment is given in 21-day cycles and continues until the cancer progresses, side effects become unacceptable, the participant decides to stop, or the study concludes. The study includes a screening period lasting up to 28 days, followed by treatment and an after-treatment period that includes a 30-day safety follow-up and a long-term survival follow-up. Participants will undergo assessments including scans reviewed centrally to monitor cancer progression, laboratory tests such as PSA levels, and evaluation of side effects. Researchers will track outcomes like radiographic progression-free survival and overall survival for up to approximately 58 months. Safety is closely monitored by an independent committee, and participants continue regular follow-up visits during and after treatment to assess response and manage any adverse events.

CONDITIONS

Brief Title

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Research Team

B

BioNTech clinical trials patient information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here